NHS National Framework for Ruxolitinib

NHS EnglandcontractFind a Tender ↗Ref ocds-h6vhtk-06891cProcurement Act 2023SME suitableplanned

View buyer

Estimated value

£105.9m

goods

Awarded value

—

Suppliers

Lots

0 awarded

Published

30 Apr 2026

This is a preliminary market engagement notice

Map the supplier landscape and document your shortlist before opening the tender. The market simulation produces a defensible audit record you can attach to your procurement file.

Run market simulation

Description

Project title: NHS National Framework for Ruxolitinib Offer reference number: CM/TNS/26/5755 Period of framework: 1 November 2026 to 31 October 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Scope

Reference: CM/TNS/26/5755
Total value: £105,900,000 excluding VAT
£127,080,000 including VAT
Above the relevant threshold
Commercial tool: Standalone contract
Contract dates: 01 Nov 2026 to 31 Oct 2027
Possible extension to 31 Oct 2029
Main category: goods
CPV classifications: 33600000
Contract locations: North East England, United Kingdom
North West England, United Kingdom
East Midlands, United Kingdom
West Midlands, United Kingdom
East of England, United Kingdom
South East England, United Kingdom
South West England, United Kingdom
Particular suitability: Small and medium-sized enterprises (SME)